Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients

Nephrology

Volumn 17, Issue 8, 2012, Pages 718-724

  Cheng, Chi Hung ^a,b,c   Chen, Yi Shyan ^d   Shu, Kuo Hsiung ^b   Chang, Horng Rong ^a   Chou, Ming Chih ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

haemodialysis; peripheral artery disease; soluble intracellular cell adhesion molecular 1; soluble vascular cell adhesion molecule 1

Indexed keywords

CELL ADHESION MOLECULE; INTRACELLULAR CELL ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTICLE; BLOOD VESSEL FISTULA; CARDIOVASCULAR RISK; DOPPLER FLOWMETRY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84868146220     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01654.x     Document Type: Article

References (23)

1. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010.
2. Kumada Y, Aoyama T, Ishii H, et al,. Long term outcome of percutaneous transluminal angioplasty in chronic hemodialysis patients with peripheral arterial disease. Nephrol. Dial. Transplant. 2008; 23: 3996-4001.
3. Plantinga LC, Fink NE, Coresh J, et al,. Peripheral vascular disease related procedures in dialysis patients: Predictors and prognosis. Clin. J. Am. Soc. Nephrol. 2009; 4: 1637-45.
4. Libby P, Ridker PM, Hansson GK,. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. J. Am. Coll. Cardiol. 2009; 54: 2129-38.
5. Brevetti G, Schiano V, Massinmo C,. Cellular adhesion molecules and peripheral artery disease. Vasc. Med. 2006; 11: 39-47.
6. Hoogeveen RC, Morrison A, Boerwinkle E, et al,. Plasma MCP-1 and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis risk in community study. Atherosclerosis 2005; 183: 301-7. (Pubitemid 41579281)
7. Papayianni A, Alexopoulos E, Giamalis F, et al,. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol. Dial. Transplant. 2002; 17: 435-41. (Pubitemid 34211140)
8. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O,. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol. Dial. Transplant. 2000; 15: 1624-30.
9. Hirsch AT, Haskal ZJ, Hertzer NR, et al,. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J. Am. Coll. Cardiol. 2006; 47: 1239-312.
10. NKF-KDOQI Clinical practice guidelines for vascular access. Am. J. Kidney Dis. 2006; 48 (Suppl 1): S248-S272.
11. Pradhan AD, Rifai N, Ridker PM,. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1 and the development of symptomatic peripheral arterial disease in men. Circulation 2002; 106: 820-25.
12. Pradhan AD, Cook NR, Rifai N, Creager MA, Ridker PM,. Symptomatic peripheral arterial disease in women-Non traditional biomarkers of elevated risk. Circulation 2008; 117: 823-31. (Pubitemid 351640684)
13. Signorelli SS, Mazzarino MC, Di Pino L, et al,. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc. Med. 2003; 8: 15-19. (Pubitemid 36781068)
14. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN,. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: Relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb. Haemost. 1998; 79: 1080-85. (Pubitemid 28297150)
15. Brevetti G, De Caterina M, Martone VD, et al,. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin. Hemorheol. Microcirc. 2001; 24: 193-9.
16. Boulbou MS, Koukoulis GN, Vasiou KG, Petinaki EA, Gourgoulianis KI, Fezoulidis IB,. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease. Int. Angiol. 2004; 23: 18-24. (Pubitemid 38811561)
17. Silvestro A, Brevetti G, Schiano V, Scopacasa F, Chiariello M,. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb. Haemost. 2005; 93: 559-63. (Pubitemid 40392547)
18. Blann AD, McCollum CN,. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 1994; 72: 151-4. (Pubitemid 24202311)
19. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K,. Reduced capacity of mononuclear cells to synthesize cytokines against an inflammatory stimulus in uremic patients. Nephron Clin. Pract. 2006; 104: c113-c119. (Pubitemid 44567791)
20. Papagianni P, Kalovoulos M, Kirmizis D, et al,. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2003; 181: 113-19. (Pubitemid 36104486)
21. Kirmizis D, Papagianni A, Dogrammatzi F, et al,. Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis. J. Atheroscler. Thromb. 2010; 17: 1256-6.
22. Rajagopalan S, Dellegrottaglien S, Furniss AL, et al,. Peripheral arterial disease in patients with end-stage renal disease. Circulation 2006; 114: 1914-22.
23. Lim PS, Chen TT, Yang SM, Chien SW, Kuo YC, Pai MA,. Prevalence and clinical correlates of peripheral arterial disease in hemodialysis patients. Acta Nephrologica 2005; 19: 113-20.